DK0669977T3 - Transformerede endothelceller - Google Patents

Transformerede endothelceller

Info

Publication number
DK0669977T3
DK0669977T3 DK93924544T DK93924544T DK0669977T3 DK 0669977 T3 DK0669977 T3 DK 0669977T3 DK 93924544 T DK93924544 T DK 93924544T DK 93924544 T DK93924544 T DK 93924544T DK 0669977 T3 DK0669977 T3 DK 0669977T3
Authority
DK
Denmark
Prior art keywords
cells
kappa
endothelial cells
activity
endothelial
Prior art date
Application number
DK93924544T
Other languages
English (en)
Inventor
Fritz H Bach
Martin Rainer De
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK0669977T3 publication Critical patent/DK0669977T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0271Chimeric vertebrates, e.g. comprising exogenous cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Animal Husbandry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK93924544T 1992-11-02 1993-10-29 Transformerede endothelceller DK0669977T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929222931A GB9222931D0 (en) 1992-11-02 1992-11-02 Organic compounds
PCT/EP1993/003015 WO1994010305A1 (en) 1992-11-02 1993-10-29 Transformed endothelial cells

Publications (1)

Publication Number Publication Date
DK0669977T3 true DK0669977T3 (da) 2000-08-07

Family

ID=10724398

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93924544T DK0669977T3 (da) 1992-11-02 1993-10-29 Transformerede endothelceller

Country Status (16)

Country Link
EP (1) EP0669977B1 (da)
JP (1) JPH08502653A (da)
KR (1) KR950704477A (da)
AT (1) ATE192492T1 (da)
AU (1) AU680636B2 (da)
CA (1) CA2143489A1 (da)
DK (1) DK0669977T3 (da)
ES (1) ES2146235T3 (da)
FI (1) FI952088A (da)
GB (1) GB9222931D0 (da)
GR (1) GR3033600T3 (da)
NO (1) NO951628L (da)
NZ (1) NZ257539A (da)
PT (1) PT669977E (da)
RU (1) RU2164415C2 (da)
WO (1) WO1994010305A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2726005B1 (fr) * 1994-10-10 1997-01-03 Adim Lignees immortalisees de cellules endotheliales cerebrales et leurs applications au traitement de differents troubles ou maladies primaires et secondaires neurologiques ou psychiatriques
AU5147996A (en) * 1995-03-24 1996-10-16 New England Deaconess Hospital Corporation Gene therapy for transplantation and inflammatory or thrombo tic conditions
US5981486A (en) * 1995-04-13 1999-11-09 Chugai Seiyaku Kabushiki Kaisha Peptide suppressing IκBα phosphorylation
JPH0959151A (ja) * 1995-08-24 1997-03-04 Kao Corp NF−κB活性化抑制剤
EP0779361A3 (en) 1995-12-15 1999-11-10 F. Hoffmann-La Roche Ag Truncated form of inhibitory kappa B protein (1kB), recombinant production and uses thereof
EP0886650A1 (en) * 1996-02-14 1998-12-30 Novartis AG Gene therapy of entothelial cells with anti-apoptotic proteins for transplantation and inflammatory conditions
AU2001231009A1 (en) 2000-01-21 2001-07-31 Beth Israel Deaconess Medical Center Use of pro-apoptotic factors in treatment of atherosclerosis
WO2006040615A2 (en) * 2003-06-11 2006-04-20 Jan Remmereit Differenciation of stem cells for therapeutic use
TW201120210A (en) 2009-11-05 2011-06-16 Hoffmann La Roche Glycosylated repeat-motif-molecule conjugates
CN103459608B (zh) 2011-04-01 2018-05-01 中外制药株式会社 重组多肽的制造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341606C (en) * 1988-03-01 2010-06-08 Whitehead Institute For Biomedical Research Activation of nf-kb precursor
DE69123981T3 (de) * 1990-10-31 2006-06-14 Cell Genesys Inc Nützliche retrovirale vektoren für die gentherapie

Also Published As

Publication number Publication date
KR950704477A (ko) 1995-11-20
FI952088A0 (fi) 1995-05-02
ATE192492T1 (de) 2000-05-15
NO951628D0 (no) 1995-04-28
RU2164415C2 (ru) 2001-03-27
AU5440494A (en) 1994-05-24
PT669977E (pt) 2000-08-31
GB9222931D0 (en) 1992-12-16
AU680636B2 (en) 1997-08-07
EP0669977A1 (en) 1995-09-06
EP0669977B1 (en) 2000-05-03
CA2143489A1 (en) 1994-05-11
NO951628L (no) 1995-07-03
ES2146235T3 (es) 2000-08-01
WO1994010305A1 (en) 1994-05-11
NZ257539A (en) 1996-08-27
FI952088A (fi) 1995-05-02
GR3033600T3 (en) 2000-09-29
JPH08502653A (ja) 1996-03-26

Similar Documents

Publication Publication Date Title
DE3280479T2 (de) Rekombinante DNS-Mittel und Verfahren
DE69420726D1 (de) Embryonische stammzelle zur herstellung von chimäre und transgen-ongulaten
DE69333466D1 (de) Herstellung von transplantatgeweben aus extrazellulärer matrix
CA2063810A1 (en) Production of vascular endothelial cell growth factor
ES2093025T3 (es) Produccion del factor de crecimiento de celulas endoteliales y adn de codificacion del mismo.
DE69534227D1 (de) Stoffe und verfahren zur beherrschung der hyperakuten abstossung von menschlichen transplantaten
EE9700018A (et) Bioloogilistesse tehiselunditesse kapseldatud rakkude kasvu kontrollimine
ES2146235T3 (es) Celulas endoteliales transformadas.
DE69434312D1 (de) Regulierung von pflanzenwachstum
ATE211177T1 (de) Expression von aktivem menschlichem protein c im milchdrüsengewebe transgener tiere
ATE71298T1 (de) Immunoregulation.
ATE360701T1 (de) Putrescin-n-methyltransferasepromotor
DK0744891T3 (da) Transgene fibrinogener
ZA843015B (en) Novel strain of trichoderma harzianum,method of isolating said strain,method of cultivating said strain,novel peptides or compounds produced from said strain,and application of said strain and of said novel peptides or of the product obtained by the cultivation method as a biologically active means in the form of a plant-disease control product
ATE286129T1 (de) Pflanzenwurzelspezifischer promotor, rekombinante vektoren und wirtszellen die diesen enthalten und korrespondierende transgene pflanzen
ATE208422T1 (de) Pflanzenverlängerungsfaktor, promotoren, kodierende sequenzen und verwendungen
DE69331434D1 (de) Mutanter AOX2 Promotor, diesen enthaltender Vektor, transformierte Zellen und Herstellung von heterologen Proteinen
ATE377084T1 (de) Transgene pflanzen und pflanzenzellen mit verminderter expression von invertaseinhibitoren
ATE90969T1 (de) Expression von fremden genen in drosophilazellen.
ATE401001T1 (de) Pflanzen zur kontrolle von schäden verursacht durch fressende insekten